Breast Cancer and Multiple MyelomaFrequency Distribution of Antineoplastic Regimens (010) (1)

Patients, n (%)

ZOMETAŽ ZOMETA Pam

No. of 4 mg 8/4 mg 90 mg

Stratum regimen N = 563 N = 524 N = 556

37

Multiple myeloma, n 186 160 167

0 11 (5.9) 10 (6.3) 11 (6.6)

1 74 (39.8) 58 (36.3) 72 (43.1)

2 43 (23.1) 43 (26.9) 41 (24.6)

3 29 (15.6) 31 (19.4) 21 (12.6)

4 17 (9.1) 11 (6.9) 12 (7.2)

? 5 12 (6.5) 7 (4.4) 10 (6.0)

PTT 8.2-7

Previous slide

Next slide

Back to first slide

View graphic version